Several subsequent studies confirmed miR-155 overexpression in breast cancer tissues [80,81,82] and recent work presented the tumor protein p53-induced nuclear protein 1 (TP53INP1) as a miR-155 target in MCF-7 cells [83]. This evidence concerns the gene TP53INP1 and breast cancer.